Suven Life Sciences Limited (BOM: 530239)

Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 13, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	26,125	21,742	10,570	13,484	8,961	2,724
Market Cap Growth	98.01%	105.69%	-21.61%	50.48%	228.97%	-91.80%
Enterprise Value	24,463	19,870	10,468	13,313	8,934	2,406
Last Close Price	119.80	99.70	48.47	85.47	64.87	19.72
Forward PE	-	3.65	3.65	3.65	3.65	1.59
PS Ratio	364.50	185.94	77.75	112.83	63.67	18.52
PB Ratio	13.60	8.05	2.82	14.02	8.30	1.90
P/TBV Ratio	15.93	8.06	2.82	14.06	8.31	1.90
PEG Ratio	0.13	0.13	0.13	0.13	0.13	0.08
EV/Sales Ratio	290.71	169.93	77.00	111.40	63.48	16.36
EV/FCF Ratio	-16.48	-	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.03	0.04	0.04
Asset Turnover	0.03	0.03	0.05	0.10	0.09	0.06
Inventory Turnover	1.14	2.30	27.66	9.10	0.26	0.09
Quick Ratio	9.50	18.00	21.03	7.13	3.42	0.68
Current Ratio	10.40	18.99	22.61	8.01	6.45	2.49
Return on Equity (ROE)	-54.98%	-32.56%	-50.17%	-119.51%	-57.41%	-49.27%
Return on Assets (ROA)	-36.70%	-24.91%	-33.21%	-66.72%	-33.54%	-30.77%
Return on Capital (ROIC)	-38.75%	-25.92%	-34.65%	-74.38%	-39.72%	-38.17%
Earnings Yield	-5.58%	-4.83%	-11.19%	-9.05%	-8.05%	-34.59%
FCF Yield	-5.68%	-5.31%	-11.25%	-10.92%	-11.42%	-50.28%
Dividend Yield	0.00%	-	-	1.17%	-	-
Buyback Yield / Dilution	-1.84%	-22.31%	-32.29%	-5.88%	-	-
Total Shareholder Return	-1.84%	-22.31%	-32.29%	-4.71%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.